Leaderboard

En | De
Sie sind hier: Gastroenterologie » Oesophagus » Neoplasie 01. Oktober 2026
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gallenwege
Leber
Magen-Darm
Oesophagus
Motilitätsstörungen
Neoplasie
Anderes
Pankreas
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 1989  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 39764  
   
Factors associated with all-cause mortality in Gastroesophageal Carcinoma in Situ: Nationwide Cohort Study.
Digestion
Nam SY, Jo J, Kim SK.
PMID: 42814640 [PubMed - as supplied by publisher]


Robotic vs Thoracolaparoscopic Esophagectomy for Esophageal Cancer: A Randomized Clinical Trial.
JAMA Surg
Berlth F, Gisbertz SS, Tagkalos E, Hadzijusufovic E, Schneider PM, Fuchs H, van Berge Henegouwen MI, Lozanovski VJ, Ruurda JP, Goense L, Schiesser M, Bruns C, Lang H, van Hillegersberg R, Grimminger PP.
PMID: 42814447 [PubMed - as supplied by publisher]


Perioperative Chemoimmunotherapy for Resectable Gastric and Gastroesophageal Junction Cancer: A Conceptual, Biomarker-Informed, and Regionally Adapted Framework.
J Gastrointest Cancer
Sagawa T, Nagashima H, Fujikawa K.
PMID: 42811236 [PubMed - indexed for MEDLINE]


Geriatric co-managed prehabilitation before esophagectomy in patients aged ≥ 65 years with esophageal cancer: a prospective feasibility study with matched historical controls.
Langenbecks Arch Surg
Völker LA, Haak E, Schlößer H, Bruns CJ, Schumacher P, Schröder W, Brinkkoetter PT.
PMID: 42809113 [PubMed - indexed for MEDLINE]


Applicability and results of the consensus definition of delayed gastric conduit emptying after esophagectomy.
Langenbecks Arch Surg
Zgurskyi P, Janje AR, Spiewok S, Kemper M, Preuschkas A, Izbicki J, Reeh M, Nickel F, Hackert T, Welsch T.
PMID: 42809050 [PubMed - indexed for MEDLINE]


Radiotherapy for overcoming immune checkpoint inhibitor resistance in esophageal squamous cell carcinoma.
Front Immunol
Du C, Li Y.
PMID: 42807764 [PubMed - indexed for MEDLINE]


Immunosuppressive tumor microenvironment and immunotherapy resistance of esophageal carcinoma.
Front Immunol
He Z, Hao H, Shu X, Ren Y, Ji Y, Zhao K, Chen Y, Han L, Hu Y.
PMID: 42807291 [PubMed - indexed for MEDLINE]


Development of a clinical prediction model using volatile organic compounds as breath biomarkers in squamous oesophageal neoplasms: ViSON, protocol for a multicentre case-control study in UK NHS hospitals.
BMJ Open
Sharma S, Murray J, Parker A, Jamel S, Antonowicz S, Phillips A, Bailey E, Fox L, Plant C, Converso V, Ellis JK, Mukherjee S, Kumar B, Lo T, Wahed S, Alchawaf A, Moore AR, Boddy A, Scott-Brown M, Thomas B, Abdelrahman T, Pucher PH, El-Sharkawy A, Forner S, Wayman J, Elshaer A, Chan D, Mcnally S, Petty R, Patil P, Bhuva N, Periyathambi J, Bhatt L, Vohra R, Sharples L, Hanna GB, ViSON Collaborators.
PMID: 42805665 [PubMed - indexed for MEDLINE]


Efficacy and safety of radiofrequency hyperthermia combined with immune checkpoint inhibitors and chemotherapy as first-line treatment for HER2-negative advanced gastric/gastroesophageal junction adenocarcinoma: A propensity score-matched study.
Hum Vaccin Immunother
Gao Y, Zhao W, Wang Q, Liu M, Wang W, Su F, Yang S, Shen X, Fan W, Zhang Y, Zhang X, du Y, Wang H, Li X, Hu W, Zhao J.
PMID: 42803704 [PubMed - indexed for MEDLINE]


Optimising proton therapy referral pathways for lung and oesophageal cancer in a Dutch interorganisational referral network: A canonical action research study.
Radiother Oncol
Ho F, Jacobs M, Heising L, Cremers P, Ou C, Meijboom B, Boersma L, Collaborative Expert Group for Action Research.
PMID: 42801959 [PubMed - as supplied by publisher]


Exosomal signaling in esophageal cancer: mechanisms, detection, and therapeutic innovations.
Clin Chim Acta
Lv C, Du S.
PMID: 42801943 [PubMed - as supplied by publisher]


Association of Alcohol Consumption with Risk of Pancreatic Cancer: A Systematic Review and Dose-Response Meta‑Analysis of Prospective Cohort Studies.
Nutr Cancer
Li J, Liu L, Sun J, Zhu J, Li T, Wei S, Lu M, Song Y, Wang Z, Wang P, Shi J, Wang K, Ye H.
PMID: 42801473 [PubMed - as supplied by publisher]


Automated detection of gastroesophageal adenocarcinoma recurrence from electronic health records.
Dis Esophagus
Okui J, Lyu HG, Prakash LR, Li JJ, Blum-Murphy MA, Ajani JA, Hofstetter WL, Rice DC, Mansfield PF, Swisher SG, Katz MH, Ikoma N.
PMID: 42801329 [PubMed - indexed for MEDLINE]


Symptom interactions and candidate intervention targets in patients with esophageal cancer: Network analysis with computer-simulated interventions.
Asia Pac J Oncol Nurs
Wen X, Liu Y, Lin Y, Qiao Y, Huang Y, Han X, Guo X, Gu D.
PMID: 42799374 [PubMed]


The Lactate-Lactylation Axis as a Metabolic-Epigenetic Framework for Therapeutic Adaptation in Esophageal Squamous Cell Carcinoma.
Cancers (Basel)
Yu J, Cui Y, Li S, Guo X, Li N, Gu Y, Jin Y, Chen Y, Li X, Yan Y, Wu Z, Zhu C, Feng L.
PMID: 42794956 [PubMed]


Recurrence Pattern and Prognostic Value of Major Pathological Response in Patients with Locally Advanced Oesophageal Squamous Cell Carcinoma Treated with Neoadjuvant Immunochemotherapy: A Multicentre Retrospective Study.
Cancers (Basel)
Wang F, Yu X, Chen H, Yan D, Yang L, Yang R, Zhu J, Yu Z, Han Y.
PMID: 42794868 [PubMed]


Construction of an Esophageal Cancer Prognostic Model Based on Mitochondrial Energy Metabolism-Related Genes and Mechanism of INHBA in Promoting Malignant Progression via the Smad2/3 Pathway.
Biomolecules
Li J, Yao Y, Li H, Shao B, Linghu E.
PMID: 42793200 [PubMed - indexed for MEDLINE]


Perioperative Circulating Tumor DNA in Resectable Gastric and Gastroesophageal Junction Adenocarcinoma: Molecular Residual Disease, Recurrence Prediction, and a Trial-Ready Framework for Treatment Adaptation.
J Gastrointest Cancer
Sagawa T, Hirakawa M, Nagashima H, Fujikawa K.
PMID: 42791456 [PubMed - indexed for MEDLINE]


Making Zolbetuximab deliverable in practice: multidisciplinary management of nausea, vomiting, gastritis, and hypoalbuminemia in first-line CLDN18.2-positive, HER2-negative gastric/GEJ adenocarcinoma.
Med Oncol
Sagawa T, Nagashima H, Fujikawa K.
PMID: 42789227 [PubMed - indexed for MEDLINE]


Correction: Heterogeneity of adjuvant therapy effectiveness across post-neoadjuvant pathologic strata in esophageal squamous cell carcinoma: a retrospective cohort study.
Esophagus
Ge Q, Feng X, Guo C, Li J, Lian J, Lu T.
PMID: 42789004 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 39764    Seite 1 von 1989  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1